Loading...

Synergy CHC Corp.

SNYRNASDAQ
Healthcare
Medical - Distribution
$0.26
$-0.02(-6.20%)
U.S. Market opens in 9h 38m

Synergy CHC Corp. Fundamental Analysis

Synergy CHC Corp. (SNYR) shows moderate financial fundamentals with a PE ratio of -0.18, profit margin of -56.98%, and ROE of 91.30%. The company generates $0.0B in annual revenue with weak year-over-year growth of -12.78%.

Key Strengths

ROE91.30%
Cash Position10.19%
PEG Ratio0.00

Areas of Concern

Operating Margin-15.57%
Current Ratio0.93
We analyze SNYR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -0.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-0.5/100

We analyze SNYR's fundamental strength across five key dimensions:

Efficiency Score

Weak

SNYR struggles to generate sufficient returns from assets.

ROA > 10%
-2.44%

Valuation Score

Excellent

SNYR trades at attractive valuation levels.

PE < 25
-0.18
PEG Ratio < 2
0.00

Growth Score

Weak

SNYR faces weak or negative growth trends.

Revenue Growth > 5%
-12.78%
EPS Growth > 10%
-5.54%

Financial Health Score

Moderate

SNYR shows balanced financial health with some risks.

Debt/Equity < 1
-1.09
Current Ratio > 1
0.93

Profitability Score

Weak

SNYR struggles to sustain strong margins.

ROE > 15%
91.30%
Net Margin ≥ 15%
-56.98%
Positive Free Cash Flow
No

Key Financial Metrics

Is SNYR Expensive or Cheap?

P/E Ratio

SNYR trades at -0.18 times earnings. This suggests potential undervaluation.

-0.18

PEG Ratio

When adjusting for growth, SNYR's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Synergy CHC Corp. at -0.11 times its book value. This may indicate undervaluation.

-0.11

EV/EBITDA

Enterprise value stands at 2.86 times EBITDA. This is generally considered low.

2.86

How Well Does SNYR Make Money?

Net Profit Margin

For every $100 in sales, Synergy CHC Corp. keeps $-56.98 as profit after all expenses.

-56.98%

Operating Margin

Core operations generate -15.57 in profit for every $100 in revenue, before interest and taxes.

-15.57%

ROE

Management delivers $91.30 in profit for every $100 of shareholder equity.

91.30%

ROA

Synergy CHC Corp. generates $-2.44 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.44%

Following the Money - Real Cash Generation

Operating Cash Flow

Synergy CHC Corp. generates limited operating cash flow of $-3.50M, signaling weaker underlying cash strength.

$-3.50M

Free Cash Flow

Synergy CHC Corp. generates weak or negative free cash flow of $-3.50M, restricting financial flexibility.

$-3.50M

FCF Per Share

Each share generates $-0.34 in free cash annually.

$-0.34

FCF Yield

SNYR converts -1.43% of its market value into free cash.

-1.43%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.18

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.10

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.09

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.93

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.91

vs 25 benchmark

ROA

Return on assets percentage

-2.44

vs 25 benchmark

ROCE

Return on capital employed

11.14

vs 25 benchmark

How SNYR Stacks Against Its Sector Peers

MetricSNYR ValueSector AveragePerformance
P/E Ratio-0.1828.65 Better (Cheaper)
ROE91.30%795.00% Weak
Net Margin-56.98%-49787.00% (disorted) Weak
Debt/Equity-1.090.40 Strong (Low Leverage)
Current Ratio0.933.73 Weak Liquidity
ROA-244.31%-20255.00% (disorted) Weak

SNYR outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Synergy CHC Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

598.25%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-8185.68%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-1404.78%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ